$10.05Billion | No. of Holdings #88
RTW INVESTMENTS, LP Performance
| Ticker | $ Bought |
|---|---|
| waystar hldg corp | 39,299,300 |
| candel therapeutics inc | 31,467,900 |
| aktis oncology inc | 28,481,600 |
| dianthus therapeutics inc | 20,817,400 |
| century therapeutics inc | 19,652,200 |
| avalo therapeutics inc | 12,794,400 |
| ocugen inc | 12,066,700 |
| ataibeckley inc | 7,080,000 |
| Ticker | % Inc. |
|---|---|
| erasca inc | 10,917 |
| tango therapeutics inc | 791 |
| celcuity inc | 452 |
| hinge health inc | 445 |
| cg oncology inc | 247 |
| milestone pharmaceuticals in | 152 |
| intuitive surgical inc | 117 |
| fulgent genetics inc | 82.83 |
| Ticker | % Reduced |
|---|---|
| jade biosciences inc | -60.45 |
| stryker corporation | -59.18 |
| larimar therapeutics inc | -52.00 |
| apellis pharmaceuticals inc | -51.93 |
| exagen inc | -50.00 |
| uniqure nv | -30.31 |
| cogent biosciences inc | -28.1 |
| beta bionics inc | -20.00 |
| Ticker | $ Sold |
|---|---|
| allurion technologies inc | -7,246,460 |
| atai beckley nv | -8,180,000 |
| rapt therapeutics inc | -55,450,800 |
| axsome therapeutics inc | -162,184,000 |
| penumbra inc | -269,403,000 |
| masimo corp | -88,869,200 |
| corvus pharmaceuticals inc | -3,446,570 |
| insulet corp | -92,264,300 |
RTW INVESTMENTS, LP has about 78.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 78.7 |
| Others | 21.3 |
RTW INVESTMENTS, LP has about 26.1% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 38.7 |
| LARGE-CAP | 26.1 |
| UNALLOCATED | 21.3 |
| SMALL-CAP | 13.3 |
About 62.4% of the stocks held by RTW INVESTMENTS, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 61.1 |
| Others | 37.6 |
| S&P 500 | 1.3 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
RTW INVESTMENTS, LP has 88 stocks in it's portfolio. About 50% of the portfolio is in top 10 stocks. MDGL proved to be the most loss making stock for the portfolio. was the most profitable stock for RTW INVESTMENTS, LP last quarter.
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc RTW INVESTMENTS, LP's holding in Acadia Pharmaceuticals Inc over time | 1.58% | 7,144,520 | $159.04M 1.58% | 0%unchanged 0 percentunchanged | |
Spyre Therapeutics Inc RTW INVESTMENTS, LP's holding in Spyre Therapeutics Inc over time | 2.09% | 4,172,000 | $210.44M 2.09% | 0%unchanged 0 percentunchanged | |
Alkermes Plc Alkermes PlcALKS RTW INVESTMENTS, LP's holding in Alkermes Plc over time | 0.59% | 1,672,360 | $59.13M 0.59% | 0%unchanged 0 percentunchanged | |
Apellis Pharmaceuticals Inc RTW INVESTMENTS, LP's holding in Apellis Pharmaceuticals Inc over time | 1.48% | 3,685,040 | $148.25M 1.48% | 51.93%decreased 51.93 percentreduced | |
Aquestive Therapeutics Inc RTW INVESTMENTS, LP's holding in Aquestive Therapeutics Inc over time | 0.31% | 7,426,470 | $30.82M 0.31% | 18.82%increased 18.82 percentadded | |
ARGX Argenx SeArgenx SeARGX | 5.16% | 709,446 | $518.07M 5.16% | 5.34%increased 5.34 percentadded | |
Arrowhead Pharmaceuticals In RTW INVESTMENTS, LP's holding in Arrowhead Pharmaceuticals In over time | 0.36% | 585,682 | $36.72M 0.36% | 0.17%increased 0.17 percentadded | |
Atai Beckley Nv Atai Beckley Nv ATAI RTW INVESTMENTS, LP's holding in Atai Beckley Nv over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Jade Biosciences Inc RTW INVESTMENTS, LP's holding in Jade Biosciences Inc over time | 0.08% | 573,205 | $8.05M 0.08% | 60.45%decreased 60.45 percentreduced | |
Avalo Therapeutics Inc RTW INVESTMENTS, LP's holding in Avalo Therapeutics Inc over time | 0.13% | 856,962 | $12.79M 0.13% | Newnew position | |
Axsome Therapeutics Inc RTW INVESTMENTS, LP's holding in Axsome Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
Beam Therapeutics Inc RTW INVESTMENTS, LP's holding in Beam Therapeutics Inc over time | 0.14% | 570,394 | $13.59M 0.14% | 0%unchanged 0 percentunchanged | |
BLTE Belite Bio IncBelite Bio IncBLTE | 1.14% | 715,332 | $114.05M 1.14% | 0%unchanged 0 percentunchanged | |
Candel Therapeutics Inc RTW INVESTMENTS, LP's holding in Candel Therapeutics Inc over time | 0.31% | 6,422,020 | $31.47M 0.31% | Newnew position | |
Capricor Therapeutics Inc RTW INVESTMENTS, LP's holding in Capricor Therapeutics Inc over time | 0.08% | 250,000 | $7.60M 0.08% | 0%unchanged 0 percentunchanged | |
Celcuity Inc Celcuity IncCELC RTW INVESTMENTS, LP's holding in Celcuity Inc over time | 3.45% | 3,039,620 | $346.94M 3.45% | 452.5%increased 452.5 percentadded | |
Cullinan Therapeutics Inc RTW INVESTMENTS, LP's holding in Cullinan Therapeutics Inc over time | 0.24% | 1,705,960 | $24.24M 0.24% | 0%unchanged 0 percentunchanged | |
CMPS Compass Pathways PlcCompass Pathways PlcCMPS | 0.58% | 10,632,400 | $58.80M 0.58% | 21.41%increased 21.41 percentadded | |
Compass Therapeutics Inc RTW INVESTMENTS, LP's holding in Compass Therapeutics Inc over time | 0.22% | 4,186,600 | $22.15M 0.22% | 67.46%increased 67.46 percentadded | |
Centessa Pharmaceuticals Plc RTW INVESTMENTS, LP's holding in Centessa Pharmaceuticals Plc over time | 0.81% | 2,054,180 | $81.59M 0.81% | 14.7%increased 14.7 percentadded | |